3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35434049 | Effective response to crizotinib of concurrent KIF5B-MET and MET-CDR2-rearranged non-small cell lung cancer: A case report. | 2022 Mar 16 | 2 |
2 | 33832282 | A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report. | 2021 Jul | 2 |
3 | 29102694 | KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma. | 2018 Mar | 1 |